Medicare Enrolled

Dr. Peter Wilcox, ARNP

Physician Assistant · Silverdale, WA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2011 NW MYHRE PL, Silverdale, WA 98383
3608301600
In practice since 2014 (12 years)
NPI: 1285049965 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wilcox from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wilcox? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wilcox

Dr. Peter Wilcox is a physician assistant in Silverdale, WA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Wilcox performed 7,163 Medicare services across 885 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wilcox received a total of $10,057 from 50 pharmaceutical and/or device companies across 515 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wilcox is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 2% volume in WA $10,057 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,163
Medicare services
Top 2% in WA for physician assistant
885
Unique beneficiaries
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~597 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 5,580 $18 $63
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,008 $75 $370
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
319 $22 $107
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
123 $93 $474
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
96 $8 $66
Anticoagulant management for warfarin
Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen.
19 $7 $33
Prothrombin time test (blood clotting)
A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process.
18 $4 $13
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,057
Total received (2021-2024)
Avg $2,514/year across 4 years
Top 2% in WA for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
515
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,012 (89.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$989 (9.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$57 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,186
2023
$2,800
2022
$3,315
2021
$1,756

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$358
Amgen Inc.
$320
Lilly USA, LLC
$170
Bayer Healthcare Pharmaceuticals Inc.
$143
Xeris Pharmaceuticals, Inc.
$135
Boehringer Ingelheim Pharmaceuticals, Inc.
$110
Novartis Pharmaceuticals Corporation
$94
Insulet Corporation
$87
Tandem Diabetes Care, Inc.
$75
Alexion Pharmaceuticals, Inc.
$74
Ascensia Diabetes Care Us Inc.
$60
AstraZeneca Pharmaceuticals LP
$59
Amphastar Pharmaceuticals, Inc.
$57
Abbott Laboratories
$51
Radius Health, Inc.
$50
BETA BIONICS, INC.
$43
Dexcom, Inc.
$40
Neurocrine Biosciences, Inc.
$40
SANOFI-AVENTIS U.S. LLC
$37
RECORDATI_RARE_DISEASES_INC.
$30
Insmed, Inc.
$28
Janssen Pharmaceuticals, Inc
$24
Kyowa Kirin, Inc.
$23
Lexicon Pharmaceuticals, Inc.
$22
Mannkind Corporation
$21
Smith+Nephew, Inc.
$20
Alnylam Pharmaceuticals Inc.
$15
Top 3 companies account for 38.8% of 2024 payments
All-time payments by company (2021-2024) ›
Novo Nordisk Inc
$1,304
Amgen Inc.
$1,267
Alexion Pharmaceuticals, Inc.
$1,063
Lilly USA, LLC
$1,019
Boehringer Ingelheim Pharmaceuticals, Inc.
$751
Xeris Pharmaceuticals, Inc.
$412
Corcept Therapeutics
$401
Novartis Pharmaceuticals Corporation
$339
SANOFI-AVENTIS U.S. LLC
$323
Abbott Laboratories
$289
Insulet Corporation
$277
AstraZeneca Pharmaceuticals LP
$224
LIFESCAN, INC.
$222
Bayer Healthcare Pharmaceuticals Inc.
$173
Radius Health, Inc.
$163
RECORDATI_RARE_DISEASES_INC.
$155
Bayer HealthCare Pharmaceuticals Inc.
$149
Janssen Pharmaceuticals, Inc
$120
AbbVie Inc.
$113
Ascensia Diabetes Care Us Inc.
$108
Medtronic, Inc.
$101
Tandem Diabetes Care, Inc.
$90
Dexcom, Inc.
$79
Kyowa Kirin, Inc.
$70
DEXCOM, INC.
$67
Amphastar Pharmaceuticals, Inc.
$57
Ultragenyx Pharmaceutical Inc.
$57
Antares Pharma, Inc.
$53
Lexicon Pharmaceuticals, Inc.
$48
Amarin Pharma Inc.
$46
MannKind Corporation
$46
EUSA Pharma (US) LLC
$45
BETA BIONICS, INC.
$43
Neurocrine Biosciences, Inc.
$40
Alnylam Pharmaceuticals Inc.
$34
Horizon Therapeutics plc
$32
Insmed, Inc.
$28
Zealand Pharma US, Inc.
$25
SI-BONE, INC.
$24
Azurity Pharmaceuticals, Inc.
$24
Mannkind Corporation
$21
Smith+Nephew, Inc.
$20
Esperion Therapeutics, Inc.
$19
Merck Sharp & Dohme LLC
$18
BOSTON SCIENTIFIC CORPORATION
$18
Supernus Pharmaceuticals, Inc.
$16
Merck Sharp & Dohme Corporation
$16
Currax Pharmaceuticals LLC
$15
CeQur Corporation
$15
ABBVIE INC.
$15
Top 3 companies account for 36.1% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Adempas · Arikayce · CONTRAVE · CREON · CeQur Simplicity · Crysvita · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EMGALITY · ENTRESTO · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · Horizant · INTELLIS ADAPTIVESTIM · ISTURISA · Inpefa · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LOKELMA · LYUMJEV · MINIMED 770G · MOUNJARO · NEXLETOL · NOCDURNA · ONETOUCH VERIO FLEX · ONPATTRO · Omnipod · Otezla · Ozempic · RECORLEV · RENASYS GO v2 HOME · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA 100/33 · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Sylvant · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tymlos · UBRELVY · VERQUVO · Vascepa · WATCHMAN · Wegovy · XARELTO · XYOSTED · ZEGALOGUE · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for physician assistant in WA.

Looking for a physician assistant in Silverdale?
Compare physician assistants in the Silverdale area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants within 10 mi
739
Per 100K population
267.2
County median income
$98,546
Nearest hospital
HARRISON MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wilcox is a clinical cardiology specialist, with above-average Medicare volume (top 2% in WA), with low-engagement industry engagement in the top 2% of WA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wilcox experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Wilcox performed 5,580 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wilcox receive payments from pharmaceutical companies?
Yes. Dr. Wilcox received a total of $10,057 from 50 companies across 515 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wilcox's costs compare to other physician assistants in Silverdale?
Dr. Wilcox's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wilcox) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →